A blood test study for early ovarian cancer detection
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study is testing a new blood test (called the EARLY panel) to see how well it can detect ovarian cancer in postmenopausal women aged 50–74. It aims to find out if the test is accurate and practical for routine screening.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 74 years old.
- You have gone through menopause, meaning no period for at least 12 months (or at least 12 months of hormone therapy for menopausal symptoms if you had a hysterectomy).
- You are willing to provide a blood sample and sign a consent form.
- You have never had ovarian cancer before.
- You still have both ovaries (you haven't had both surgically removed).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a blood test to see if it can catch ovarian cancer early. You may be eligible if you have been recently diagnosed with ovarian cancer and haven't started treatment yet.
This study is testing a new blood test that may help detect ovarian cancer earlier. Researchers want to see if it can tell the difference between people with ovarian cancer and those without it.
This trial checks whether a “liquid biopsy,” a blood test, can help doctors tell apart different causes of a suspicious pelvic/ovarian mass and help with early detection. It may help avoid uncertainty before surgery by adding test results from blood along with imaging and standard markers.
This trial tests a new blood-based test (OCS) that looks for tiny particles from tumor cells to watch for cancer returning after initial treatment. It is for women with ovarian cancer whose CA125 levels were normal before starting treatment.
This study looks at how well a blood test called CA-125, along with other markers and checkups, can detect ovarian cancer early. It’s for women considered low risk who will do regular blood tests and possibly a vaginal ultrasound if results suggest it.
This study looks at changes in blood platelets to see if they can help detect ovarian cancer earlier. It is for women who have a new ovarian or pelvic mass and are about to have a biopsy or surgery.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.